This article talks about three health care companies that might help your money grow better this quarter. These companies are Gilead Sciences, UnitedHealth Group, and Verve Therapeutics Inc. They have a special score called RSI which shows if their prices are too low or not. When the score is below 30, it means the price is very low and might go up soon. So, people who invest in these companies could make more money later. Read from source...

1. Introduction: The introduction of the article is vague and does not provide any clear information about what makes these three stocks stand out among other health care options. It also uses a clickbait title that promises to rescue your portfolio without providing any evidence or details on how this can be achieved. The introduction should be more informative, objective, and persuasive to attract readers' attention.

2. Verve Therapeutics Inc: The section about Verve Therapeutics is incomplete and ends abruptly, leaving the reader wondering what happened to the trial and how it affects the stock performance. The article should provide a complete summary of the trial results, as well as an analysis of how they impact the company's future prospects and market value.

3. Gilead Sciences (NASDAQ:GILD): The section about Gilead Sciences is too brief and does not explain why this stock is one of the best choices for investors in the health care sector. The article should include more information on the company's products, services, growth strategies, competitive advantages, financial performance, and recent news that could affect its stock price.

4. UnitedHealth Group (NYSE:UNH): The section about UnitedHealth Group is also too brief and does not provide any convincing reasons to invest in this company. The article should highlight the company's leadership position in the health care industry, its diversified portfolio of services and products, its strong financial performance and earnings guidance, as well as its recent acquisitions that could boost its growth potential.

5. Conclusion: The conclusion of the article is weak and does not summarize the main points or provide any actionable recommendations for readers who are interested in investing in health care stocks. The article should restate the key reasons why these three stocks are good choices, as well as provide some guidance on how to buy them at the best possible price and time.

First, I will provide a brief summary of each stock mentioned in the article. Then, I will give my opinion on whether they are good or bad investments based on their current performance, potential growth, and risk factors. Finally, I will rank them from best to worst according to my criteria.